New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
07:10 EDTNEONeoGenomics validates and launches new detection test for the CALR gene
NeoGenomics announced that it has validated and launched a new test for the detection of mutations in the calreticulin, or CALR, gene. The CALR gene is a novel biomarker that was reported to be specific for myeloproliferative neoplasms for the first time at the annual meeting of the American Society of Hematology last month. Since then, findings on the CALR gene have been published in the three articles referenced below.
News For NEO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2015
07:51 EDTNEONeoGenomics lowers FY15 revenue guidance to 100M-$103M from $103M-$108M
Consensus $103.78M. NeoGenomics reiterated its expectation of a return to profitability in the second half of 2015.
07:21 EDTNEONeoGenomics reports Q2 EPS 0c, consensus (1c)
Subscribe for More Information
July 22, 2015
07:09 EDTNEONeoGenomics expands multimodality cancer profile testing
NeoGenomics expanded its comprehensive multimodality NeoTYPE tumor-type specific cancer profiling tests to include new profiles for head and neck tumors, pancreatic cancer, liver cancer, sarcoma, and for cancers of unknown primary. These new tests integrate a variety of technologies, including next generation sequencing, viral in-situ hybridization, FISH, and immunohistochemistry. A number of new tests are being added to NeoGenomics cancer diagnostic test menu.
July 20, 2015
07:07 EDTNEONeoGenomics launches germline cancer predisposition testing
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use